Home ILIAS Biologics

ILIAS Biologics

In operation
Series B
Therapeutic Exosome Developer

Basic Information

ILIAS Biologics is a biotechnology company specializing in therapeutic molecules. The platform technology adopted by the company enables experts to load large therapeutic molecules into exosomes. ILIAS Biologics is developing various therapeutic exosomes, which may serve as potential treatments for a range of refractory conditions in sepsis, preterm birth, and inflammatory and metabolic diseases.
ILIAS Biologics, Inc.
Daejeon,DaejeonMetropolitanCity,SouthKorea
101~500 people
January 01, 2015
contact@iliasbio.com